Cargando…

Ivabradine improves survival and attenuates cardiac remodeling in isoproterenol‐induced myocardial injury

This study investigated whether ivabradine, a selective I(f) current inhibitor reducing heart rate (HR), is able to improve survival and prevent left ventricular (LV) remodeling in isoproterenol‐induced heart damage. Wistar rats were treated for 6 weeks: controls (n = 10), ivabradine (10 mg/kg/day o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Simko, Fedor, Baka, Tomas, Repova, Kristina, Aziriova, Silvia, Krajcirovicova, Kristina, Paulis, Ludovit, Adamcova, Michaela
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Short Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8451821/ https://www.ncbi.nlm.nih.gov/pubmed/33098700 http://dx.doi.org/10.1111/fcp.12620

Ejemplares similares

Sacubitril/Valsartan and Ivabradine Attenuate Left Ventricular Remodelling and Dysfunction in Spontaneously Hypertensive Rats: Different Interactions with the Renin–Angiotensin–Aldosterone System
por: Simko, Fedor, et al.
Publicado: (2022)

Effect of Ivabradine on a Hypertensive Heart and the Renin-Angiotensin-Aldosterone System in L-NAME-Induced Hypertension
por: Simko, Fedor, et al.
Publicado: (2018)

Ivabradine Ameliorates Kidney Fibrosis in L-NAME-Induced Hypertension
por: Stanko, Peter, et al.
Publicado: (2020)

Effect of Melatonin on the Renin-Angiotensin-Aldosterone System in l-NAME-Induced Hypertension
por: Simko, Fedor, et al.
Publicado: (2018)

Cardiovascular therapeutics: A new potential for anxiety treatment?
por: Repova, Kristina, et al.
Publicado: (2022)

Melatonin as a Potential Approach to Anxiety Treatment
por: Repova, Kristina, et al.
Publicado: (2022)

Lactacystin-induced kidney fibrosis: Protection by melatonin and captopril
por: Repova, Kristina, et al.
Publicado: (2022)

Hypertension and Cardiovascular Remodelling in Rats Exposed to Continuous Light: Protection by ACE-Inhibition and Melatonin
por: Simko, Fedor, et al.
Publicado: (2014)

Lactacystin-Induced Model of Hypertension in Rats: Effects of Melatonin and Captopril
por: Simko, Fedor, et al.
Publicado: (2017)

Renin–Angiotensin–Aldosterone System: Friend or Foe—The Matter of Balance. Insight on History, Therapeutic Implications and COVID-19 Interactions
por: Simko, Fedor, et al.
Publicado: (2021)

Ivabradine and Blood Pressure Reduction: Underlying Pleiotropic Mechanisms and Clinical Implications
por: Simko, Fedor, et al.
Publicado: (2021)

The Impact of microRNAs in Renin–Angiotensin-System-Induced Cardiac Remodelling
por: Adamcova, Michaela, et al.
Publicado: (2021)

Peripheral and Central Effects of Melatonin on Blood Pressure Regulation
por: Pechanova, Olga, et al.
Publicado: (2014)

New Developments in the Pharmacological Treatment of Hypertension: Dead-End or a Glimmer at the Horizon?
por: Paulis, Ludovit, et al.
Publicado: (2015)

Angiotensin A/Alamandine/MrgD Axis: Another Clue to Understanding Cardiovascular Pathophysiology
por: Hrenak, Jaroslav, et al.
Publicado: (2016)

Melatonin as a rational alternative in the conservative treatment of resistant hypertension
por: Simko, Fedor, et al.
Publicado: (2019)

The Novel Mas agonist, CGEN-856S, Attenuates Isoproterenol-Induced Cardiac Remodeling and Myocardial Infarction Injury in Rats
por: Savergnini, Sílvia Q., et al.
Publicado: (2013)

Effects of ivabradine on ventricular electrophysiological remodeling after myocardial infarction in rats
por: Jiang, Li-ping, et al.
Publicado: (2020)

Sulforaphane Attenuates Isoproterenol-Induced Myocardial Injury in Mice
por: Song, Lijuan, et al.
Publicado: (2020)

CD47 Deficiency Attenuates Isoproterenol-Induced Cardiac Remodeling in Mice
por: Zuo, Zhi, et al.
Publicado: (2019)

Initiation of ivabradine in cardiogenic shock
por: Chiu, Michael H., et al.
Publicado: (2019)

Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers: potential allies in the COVID-19 pandemic instead of a threat?
por: Simko, Fedor, et al.
Publicado: (2021)

Monitoring Non-dipping Heart Rate by Consumer-Grade Wrist-Worn Devices: An Avenue for Cardiovascular Risk Assessment in Hypertension
por: Baka, Tomas, et al.
Publicado: (2021)

Commentary: Effect of Angiotensin-Converting-Enzyme Inhibitor and Angiotensin II Receptor Antagonist Treatment on ACE2 Expression and SARS-CoV-2 Replication in Primary Airway Epithelial Cells
por: Simko, Fedor, et al.
Publicado: (2022)

Chronotherapy of cardiovascular pathologies: a hopeful strategy
por: Simko, Fedor, et al.
Publicado: (2022)

MBNL1 regulates isoproterenol‐induced myocardial remodelling in vitro and in vivo
por: Xu, Yao, et al.
Publicado: (2020)

Ginsenoside Re Attenuates Isoproterenol-Induced Myocardial Injury in Rats
por: Wang, Quan-wei, et al.
Publicado: (2018)

The effect of ginger (Zingiber officinale) feed on cardiac biomarker in medium-dose isoproterenol-induced myocardial toxicity
por: Ojo, Alaba Olumide, et al.
Publicado: (2021)

New onset migraine with aura after treatment initiation with ivabradine
por: Sprenger, Till, et al.
Publicado: (2013)

Alternative RAS in Various Hypoxic Conditions: From Myocardial Infarction to COVID-19
por: Rajtik, Tomas, et al.
Publicado: (2021)

Methylglyoxal attenuates isoproterenol-induced increase in uncoupling protein 1 expression through activation of JNK signaling pathway in beige adipocytes
por: Ng, Su-Ping, et al.
Publicado: (2021)

Development and Validation of RP-HPLC Method for the Estimation of Ivabradine Hydrochloride in Tablets
por: Seerapu, Sunitha, et al.
Publicado: (2010)

Therapeutic Use and Molecular Aspects of Ivabradine in Cardiac Remodeling: A Review
por: Kamisah, Yusof, et al.
Publicado: (2023)

Puerarin attenuates isoproterenol-induced myocardial hypertrophy via inhibition of the Wnt/β-catenin signaling pathway
por: Wang, Xiaoying, et al.
Publicado: (2022)

The Effect of Ivabradine on the Human Atrial Myocardial Contractility in an In Vitro Study
por: Chaban, Ryan, et al.
Publicado: (2019)

Ivabradine in sepsis
por: Nair, Abhijit S, et al.
Publicado: (2013)

Effects of Curcumin Nanoparticles in Isoproterenol-Induced Myocardial Infarction
por: Boarescu, Paul-Mihai, et al.
Publicado: (2019)

Isoproterenol-Induced Cardiomyopathy Recovery Intervention: Amlexanox and Forskolin Enhances the Resolution of Catecholamine Stress-Induced Maladaptive Myocardial Remodeling
por: Adzika, Gabriel Komla, et al.
Publicado: (2021)

Exogenous Hydrogen Sulfide Supplement Attenuates Isoproterenol-Induced Myocardial Hypertrophy in a Sirtuin 3-Dependent Manner
por: Zhang, Jingyao, et al.
Publicado: (2018)

Ivabradine promotes angiogenesis and reduces cardiac hypertrophy in mice with myocardial infarction
por: Wu, Xiangqi, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_c7hgf5h730vc9a1go3lvkvfipk